Latest news in cancer
Breyanzi – New CAR T-Cell therapy from BMS
July 2021: Breyanzi (Lisocabtagene maraleucel; liso-cel), a novel CD19-directed chimeric antigen receptor (CAR) T cell treatment developed by Bristol Myers...
Easily adoptable methods to improve outcomes in treatment of gastroesophageal cancers
July 9th 2021: During the European Society for Medical Oncology (ESMO) World Congress on Gastrointestinal Cancer 2021, two scientists from Roswell Park...
More than 12% of newly diagnosed lung cancer patients newer smoked cigarettes – study suggests
July 7th 2021 : Tobacco smoking is the leading cause of lung cancer, accounting for over 80% of all fatalities from the disease. People who do not smoke,...
Colorectal cancer latest screening guidelines
July 6th 2021 : Colorectal cancer is the among most prevalent cause of cancer death in the the world. Regular screening, on the other hand, can detect...
CAR T-Cell therapy for T-cell acute lymphoblastic leukaemia (T-ALL)
June 2021 : As per our resources, a hospital in China has developed CAR T-Cell therapy for T-cell acute lymphoblastic leukaemia (T-ALL). The expressing protein...
COVID-19 Vaccine – All that you wanted to know
Dr. Julie Gralow answers queries on COVID-19 vaccine. How can we be sure the vaccines are safe if they were produced and approved in such a short period of...
Cancer associated with AIDS
Acquired Immunodeficiency Syndrome (AIDS) is a potentially life threatening condition caused by the Human Immunodeficiency Virus (HIV) and is transmitted from...
Lonsurf is approved by FDA for recurrent, metastatic gastric and gastroesophageal junction adenocarcinoma
Trifluridine/tipiracil tablets (LONSURF, Taiho Pharmaceutical Co., Ltd.) were approved by the Food and Drug Administration on February 22, 2019 for adult...
Pembrolizumab is approved by FDA for adjuvant treatment of melanoma
On February 15, 2019, pembrolizumab (KEYTRUDA, Merck) was approved by the Food and Drug Administration for the adjuvant treatment of patients with melanoma...
Caplacizumab-yhdp approved by FDA
On February 6, 2019, in conjunction with plasma exchange and immunosuppressive treatment, the Food and Drug Administration approved caplacizumab-yhdp (CABLIVI,...
Cabozantinib is FDA-approved for hepatocellular carcinoma
On January 14, 2019, cabozantinib (CABOMETYX, Exelixis, Inc.) was approved by the Food and Drug Administration for patients with hepatocellular...
Radiation therapy
Radiation therapy in treatment of cancer Radiation therapy is a type of cancer treatment that destroys cancer cells using beams of intense radiation. Very...
Need help? Our team is ready to assist you.
We wish a speedy recovery of your dear and near one.